Results 11 to 20 of about 1,112,270 (253)

Antiphospholipid Antibodies and Systemic Scleroderma

open access: yesTurkish Journal of Hematology, 2013
Objective: Antiphospholipid antibodies (APLs) could be associated with an increased risk of vascular pathologies in systemic scleroderma. The aim of our study was to search for APLs in patients affected by systemic scleroderma and to evaluate their ...
Awa Oumar Touré   +8 more
doaj   +2 more sources

Mimics of scleroderma

open access: yesIndian Journal of Rheumatology, 2017
Systemic sclerosis is a rare autoimmune connective tissue disorder characterised typically by tightening and tethering of skin. However, several other disorders are also characterised by hardening and thickening of skin.
Kaveri K Nalianda   +3 more
doaj   +1 more source

Modern Pathogenetic Mechanisms of Systemic Scleroderma [PDF]

open access: yes, 2023
Systemic scleroderma is a chronic and often progressive autoimmune inflammation of the connective tissue, characterized by fibrosis of the skin and internal organs, widespread vascular lesions with unknown etiology, and heterogeneous clinical ...
Botirbekov Abdurashid Nazarkulovich
core   +1 more source

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group [PDF]

open access: yes, 2012
INTRODUCTION: Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known.
Smith, Vanessa   +87 more
core   +1 more source

A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis. [PDF]

open access: yes, 2015
In scleroderma (systemic sclerosis, SSc), persistent activation of myofibroblast leads to severe skin and organ fibrosis resistant to therapy. Increased mechanical stiffness in the involved fibrotic tissues is a hallmark clinical feature and a cause of ...
Ayuko Takahashi (789901)   +47 more
core   +1 more source

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients [PDF]

open access: yes, 2001
Patients with scleroderma receiving Iloprost as a treatment for severe Raynaud's phenomenon report a reduction in skin tightness, suggesting that this drug inhibits skin fibrosis.
Stratton, R   +27 more
core   +1 more source

Systemic Scleroderma with Linear Scleroderma.

open access: yesNishi Nihon Hifuka, 2002
53歳の女性にみられた線状強皮症を伴った全身性強皮症の1例を報告した。1975年頃より間質性肺炎と手指の硬化があり,当院呼吸器科で全身性強皮症としてプレドニンの内服治療を受けていた。数年前より手指の硬化が著明になると共に前胸部に皮下硬結を自覚。数ヵ月前より皮下硬結の延長が認められたため当科を受診した。初診時,前胸部に淡紅色の線状を呈する皮下硬結が認められた。血液検査所見では,抗核抗体が320倍と陽性,KL-6も643 U/mlと上昇していた。胸部X線·CT像では,間質性肺炎が認められた。前胸部の皮下硬結よりの皮膚生検で真皮の膠原線維の増生と真皮血管周囲の軽度リンパ球浸潤がみられた。以上の所見より,線状強皮症を伴った全身性強皮症と診断した ...
YAMAMURA, Mahiro   +2 more
openaire   +1 more source

Renal perfusion in scleroderma patients assessed by microbubble-based contrast-enhanced ultrasound [PDF]

open access: yes, 2012
OBJECTIVES: Renal damage is common in scleroderma. It can occur acutely or chronically. Renal reserve might already be impaired before it can be detected by laboratory findings.
Himsel, Andrea   +12 more
core   +1 more source

Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection [PDF]

open access: yes, 2013
Chronic rejection remains a potential long-term consequence of hand composite tissue allotransplantation (CTA). Scleroderma has already been proposed as a model for chronic facial allograft rejection based on potential parallels of observed progression ...
Puri, A   +6 more
core   +1 more source

Osteopetrosis in a Patient of Systemic Sclerosis Sine Scleroderma: A Rare Association

open access: yesIndian Journal of Radiology and Imaging, 2021
Systemic sclerosis is a connective tissue disorder of unknown etiology. Although it is a multisystemic disorder, skin thickening is considered as a hallmark of the disease.
Saroj K. Pati   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy